Closed
SectorHealthcare
3.39 1.19
24h
Min
3.32
Max
3.41
Income | -16M 3M |
---|---|
Sales | -13M 46M |
P/E Sector Avg | 4.423 39.857 |
Profit margin | 6.464 |
Employees | 172 |
EBITDA | -14M 4M |
Recommendations | Sell |
---|---|
12 Months Forecast | -12.79% downside |
Next Earnings | 31 lip 2025 |
---|
Market Cap | 12M 171M |
---|---|
Previous open | 2.2 |
Previous close | 3.39 |
By Acuity
16%
84%
25 / 376 Ranking in Healthcare
By Trading Central
Confidence
Weak Bullish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 3 USD -12.79%
High 4 USD
Low 2 USD
Based on 2 Wall Street analysts offering 12 month price targets forPuma Biotechnology Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Very Strong Bullish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$